All posts by: Michael Zand

About Michael Zand

Gene Therapy, ‘Medical Chips’ Top Advances Predicted for 2018 – Newsmax

Continue reading

2018-01-09 NEWS

Newsmax

Gene Therapy, ‘Medical Chips’ Top Advances Predicted for 2018
Newsmax
The advance marks the latest in a series of breakthoughs in gene therapy that have emerged in recent years, from new medications that target gene defects to diagnostic tests for heart disease, cancer, and Alzheimer’s disease. Genetics are expected to

Continue reading

2018-01-09 NEWS

Rare Disease Report

BioMarin CEO Speaks on Gene Therapy for Hemophilia at JP Morgan
Rare Disease Report
At the annual J.P. Morgan Healthcare Conference in San Francisco, BioMarin Chief Executive Officer Jean-Jacques Bienaime spoke about the company’s development of valoctocogene roxaparvovec, a gene therapy in development for the treatment of Hemophilia

Continue reading

2018-01-09 NEWS

Topeka Capital Journal

New stem cell method sheds light on a tell-tale sign of heart disease
Medical Xpress
The team, led by Morgridge Institute Fellow Dave Vereide, describes in the Jan. 9, 2018 issue of Stem Cell Research a new method of creating human arterial endothelial cells from cord blood and adult bone marrow sources. These cells, which have been
Kansas stem cell researchers may open the door to the future of healingTopeka Capital Journal
GH gets first stem cell transplant unit in govt. sectorThe Hindu
Nobel Prize Doctor Yamanaka: Stem Cell Progress ‘Just the Beginning’JAPAN Forward (press release) (blog)
Business Wire (press release) –Phys.Org –Markets Insider
all 74 news articles »